Page 5 - Small Cell News Today

While patients with other diseases have benefitted from the use of biomarkers, the lack of a biomarker in small cell lung cancer remains a disappointment, said Tom Stinchcombe, MD, medical oncologist, Duke Cancer Institute.

Two recent decisions issued this summer by different United States Courts of Appeals interpreting Sections 253 and 332 of the Communications Act demonstrate the continuing uncertainty...

/PRNewswire/ -- The GaN Semiconductor Device Market is expected to reach USD 28.3 billion by 2028 from USD 21.1 billion in 2023, at a CAGR of 6.1% during the...

/PRNewswire/ -- The "Mission Critical Communications Market by Enterprise, Industrial and Government Solutions 2023 - 2028" report has been added to...

Study Reveals LEMS Often Goes Undiagnosed in U.S. Patients with Small Cell Lung Cancer...

CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for

Second-line treatments for small cell lung cancer are effective, but the outcomes are modest, explained Tom Stinchcombe, MD, medical oncologist, Duke Cancer Institute.

Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "5G Indoor Deployment Strategies and Technical Trends" report has been added to ResearchAndMarkets.com's...

Connecting the Next Generation RF INDUSTRIES 2022 ...

/PRNewswire/ -- The 5G from the space market is valued at USD 300 million in 2023 and is projected to reach USD 3,693 million by 2028, at a CAGR of 65.1% from...